Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,205,170
-$20,422,175 QoQ
Shares Held
57,030
-77.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#501
of 2,266 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Sep 30, 2025CallValue
$999,000
CallShares
9,000
PutValue
$999,000
PutShares
9,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $100,420,553 across 10 Drug Manufacturers - General names. GILD ranks #4 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
240,327 | $48,495,411 | |
| 2 | ABBV |
AbbVie Inc.
|
104,287 | $26,242,780 | |
| 3 | GSK |
GSK plc
|
199,265 | $10,445,471 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
57,030 | $7,205,170 | |
| 5 | NVS |
Novartis AG
|
16,468 | $2,580,864 | |
| 6 | MRK |
Merck & Co., Inc.
|
15,528 | $1,995,348 | |
| 7 | JNJ |
Johnson & Johnson
|
6,461 | $1,640,900 | |
| 8 | SNY |
Sanofi
|
15,897 | $678,166 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,205,170 | 57,030 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $999,000 | 9,000 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $999,000 | 9,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $27,627,345 | 248,895 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $46,848,451 | 422,553 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,305,258 | 74,121 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $47,231,736 | 511,332 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $49,506,765 | 590,491 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $53,374,463 | 777,940 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,325,000 | 100,000 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $18,899,598 | 258,015 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $31,279,338 | 386,117 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $896,357 | 11,961 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $2,676,363 | 32,257 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,444,244 | 75,064 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,457,827 | 120,892 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,846,171 | 175,476 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,306,405 | 122,900 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,818,877 | 93,911 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $5,922,499 | 91,637 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,788,582 | 30,700 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $813,444 | 12,873 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $2,554,177 | 33,197 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,004,913 | 26,818 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||